Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
0.5800 x 9 0.5900 x 10
Pre-market by (Cboe BZX)
0.5833 +0.0167 (+2.95%) 04/24/25 [NASDAQ]
0.5800 x 9 0.5900 x 10
Pre-market 0.5833 unch (unch) 15:59 ET
Profile for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Oncolytics Biotech Inc 804 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 CAN

www.oncolyticsbiotech.com Employees: 28 P: 403-670-7380 F: 403-283-0858

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Key Statistics

Overview:

Market Capitalization, $K 50,410
Enterprise Value, $K 38,780
Shares Outstanding, K 86,422
Annual Sales, $ 0 K
Annual Net Income, $ -23,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,730 K
EBIT, $ -25,540 K
EBITDA, $ -25,230 K
60-Month Beta 1.07
% of Insider Shareholders 0.10%
% of Institutional Shareholders 6.82%
Float, K 86,336
% Float 99.90%
Short Volume Ratio 0.39

Growth:

1-Year Return -44.97%
3-Year Return -55.81%
5-Year Return -61.63%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 57.14%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 03/07/25
Next Earnings Date 05/08/25 [--]
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Qtr 22.22%
EPS Growth vs. Prev Year -75.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-19 on 05/25/18

ONCY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -223.42%
Return-on-Assets % -113.24%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 10.96
Book Value/Share 0.05
Interest Coverage -1.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective